CORINDUS VASCULAR ROBOTICS, INC
CVRS
CVRS was delisted on the 28th of October, 2019.
50 hedge funds and large institutions have $83.5M invested in CORINDUS VASCULAR ROBOTICS, INC in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 8 closing their positions.
187% more capital invested
Capital invested by funds: $29.1M → $83.5M (+$54.4M)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
2% less funds holding
Funds holding: 51 → 50 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$12.3M |
| 2 |
HEC
Hudson Executive Capital
New York
|
+$9.23M |
| 3 |
BlackRock
New York
|
+$1.89M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$232K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.53M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$1.45M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$707K |
| 4 |
Millennium Management
New York
|
-$238K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$81.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$62K | -88,112 | Closed |
|
52
Citigroup
New York
| – | -$44.9K | -55,140 | -100% |
|
|
CS
53
Credit Suisse
Zurich,
Switzerland
| – | -$15K | -20,916 | Closed |
|
|
KLI
54
Kelman-Lazarov Inc
Memphis,
Tennessee
| – | -$13.4K | -19,177 | Closed |
|
55
Principal Financial Group
Des Moines,
Iowa
| – | -$9K | -12,273 | Closed |
|
|
VKH
56
Virtu KCG Holdings
New York
| – | -$8K | -11,109 | Closed |
|
57
Legal & General Group
London,
United Kingdom
| – | -$2K | -2,908 | Closed |
|
58
Barclays
London,
United Kingdom
| – | -$611 | -750 | -73% |
|
CVRS Hedge Fund Activity: Q1 2017 in Review
50 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q1 2017, worth a combined $83.5M — up 187% from $29.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CVRS positions and 8 closed out — a net gain of 3 holders — while 14 added to existing stakes and 14 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $12.3M. The largest seller was Morgan Stanley, cutting an estimated $1.53M.
- 50 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q1 2017, down from 51 in Q4 2016.
- Funds reported $83.5M of CORINDUS VASCULAR ROBOTICS, INC stock for Q1 2017, up 187% quarter-over-quarter.
- 11 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q1 2017 and 8 closed out, a net change of +3 holders.
- The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q1 2017 was Consonance Capital Management, an estimated $12.3M added.
- The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q1 2017 was Morgan Stanley, an estimated $1.53M sold.
Based on aggregated 13F filings for Q1 2017.